World’s Top 20 Companies in Aortic Endografts Market 2025: Industry Intelligence Report by Spherical Insights (2024–2035)
RELEASE DATE: Mar 2026 Author: Spherical InsightsRequest Free Sample Speak to Analyst
Description
According to a research report published by Spherical Insights & Consulting, The Global Aortic Endografts Market Size is projected to grow from USD 3.27 Billion in 2024 to USD 6.82 Billion by 2035, at a CAGR of 6.91% during the forecast period 2025-2035. Aortic aneurysms (AAA/TAA) are becoming more common, the population is getting older, and minimally invasive techniques like TEVAR and EVAR are the key drivers of the market.
Introduction
Aortic endografts, also known as endovascular stent grafts, are specialized, flexible, tube-like devices typically made of metal and polymer that are inserted into the aorta through a catheter to strengthen the arterial wall from the inside in order to treat weak spots, including aneurysms. They provide a less invasive substitute for open surgery, which reduces mortality and recovery periods. In February 2023, UK NHS data showed about 274,800 men were offered abdominal aortic aneurysm (AAA) screening with 1,794 aneurysms detected, a statistic often cited in analyses of the growing Global Aortic Endografts Market. In Asia-Pacific, rising cardiovascular disease prevalence and government healthcare investments are fueling the expansion of specialized cardiac and vascular care infrastructure, supporting greater adoption of advanced aortic endograft procedures and related treatments. To enhance product portfolios, major industry players are concentrating on alliances, mergers and acquisitions, and R and D, especially with businesses like Medtronic, Cook Medical, and W.L. Gore and Associates. Developing healthcare infrastructure and increasing awareness in countries like India and China provide substantial growth opportunities.
Navigate Future Markets with Confidence: Insights from Spherical Insights LLP
The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Aortic Endografts Market.
Aortic Endografts Market Size & Statistics
- The Market Size for Aortic Endografts Was Estimated to be worth USD 3.27 Billion in 2024.
- The Market Size is Going to Expand at a CAGR of 6.91% between 2025 and 2035.
- The Global Aortic Endografts Market Size is anticipated to reach USD 6.82 Billion by 2035.
- Asia Pacific is estimated to generate the highest demand during the forecast period in The Aortic Endografts Market.
- North America is projected to grow the fastest during the forecast period in The Aortic Endografts Market
Regional Growth and Demand
North America is expected to grow the fastest during the forecast period in the aortic endografts market. The rising prevalence of aortic aneurysms and increasing adoption of minimally invasive endovascular procedures in the United States and Canada are driving the demand for advanced aortic endografts. In 2023, the region witnessed growing investments in vascular surgery technologies and the expansion of specialized cardiovascular treatment centers. The United States led the market growth, supported by strong research and development activities and the presence of major medical device manufacturers. In April 2025, MicroPort Endovascular received approval for its Talos Thoracic Stent Graft System in Brazil and Argentina, marking a significant step in expanding advanced aortic endograft availability and strengthening the global aortic endografts market.
Asia Pacific is anticipated to generate the highest demand during the forecast period in the aortic endografts market. The region's market growth is driven by rising cardiovascular disease prevalence, expanding healthcare infrastructure, and increasing adoption of minimally invasive vascular treatments in countries such as China and India. In 2024, several medical device manufacturers in the region announced capacity expansions and technology investments to support the growing demand for advanced endovascular therapies. The regional market is further propelled by large-scale investments in healthcare infrastructure and the rapid growth of specialized cardiovascular treatment centers. In August 2024, Terumo India launched the Treo Abdominal Stent-Graft System for endovascular aneurysm repair (EVAR), marking a significant innovation in the global aortic endografts market and supporting the adoption of advanced aortic therapies in emerging markets.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Aortic Endografts Market.
Top 10 trends in the Aortic Endografts Market
- Rise of Fenestrated and Branched Endografts
- Expansion of EVAR Procedures
- Shift Towards Patient-Specific Solutions
- Growth in Ambulatory Surgical Centers
- Advanced Imaging and AI Integration
- Enhanced Delivery Systems
- Increased Focus on Long-Term Durability
- Expansion into Emerging Markets
- Increased Use of "Off-the-Shelf" Solutions
- Focus on Physician-Modified Endografts (PMEGs)
Growth of Fenestrated and Branched Endografts (FEVAR/BEVAR):
Complex abdominal (AAA) and thoracic (TAA) aneurysms involving visceral arteries are increasingly being treated using bespoke or commercial fenestrated and branched grafts.
Extension of EVAR Protocols:
Due to shorter hospital stays, lower mortality, and less surgical trauma, endovascular aneurysm repair (EVAR) is still gaining market share over open surgery.
Transition to Patient-Specific Solutions:
There is a growing need for 3D-printed, patient-specific endografts that are tailored to various aortic anatomies in order to improve clinical results.
Growth in Ambulatory Surgical Centers (ASCs):
EVAR treatments are increasingly being performed in outpatient settings like ASCs, which lowers costs and increases patient accessibility.
Advanced Imaging and AI Integration:
AI-based software is being utilized more frequently for precise, customized device selection, improving procedural success rates, and pre-operative anatomical planning.
Empower your strategic planning:
Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the temporary power market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Aortic Endografts Market.
Top 20 Companies Leading the Aortic Endografts Market
- Medtronic
- Terumo Aortic
- L. Gore & Associates
- Endologix
- MicroPort Endovascular
- Cook Medical
- Bolton Medica
- CryoLife
- Lombard Medical
- JOTEC
- Abbott Vascular
- Braun Melsungen
- Philips Healthcare
- Siemens Healthineers
- Cardinal Health
- Boston Scientific
- Medicover
- GE Healthcare
- InspireMD
- Cordis Corporation
- Medtronic
Headquarter: Dublin, Ireland.
It is a multinational medical device company originally founded in 1949 by Earl Bakken and Palmer Hermundslie. The company specializes in developing and manufacturing advanced medical technologies, including cardiovascular devices, surgical systems, neuroscience therapies, diabetes management solutions, and patient monitoring equipment. Medtronic operates globally with manufacturing, research, and innovation centers across North America, Europe, and Asia, serving healthcare providers in more than 150 countries.
- Terumo Aortic
Headquarter: Inchinnan, Scotland,
Terumo Aortic is a global medical device company specializing in the development and manufacturing of vascular and endovascular graft technologies used in the treatment of aortic diseases. The company operates as a division of Terumo Corporation, which was founded in 1921. Terumo Aortic focuses on producing surgical grafts, stent graft systems, and hybrid devices for treating complex aortic aneurysms and dissections. The company operates advanced manufacturing and research facilities across Europe, North America, and Asia, serving cardiovascular surgeons and healthcare providers worldwide.
- L. Gore & Associates
Headquarter: Newark, Delaware, United States.
- L. Gore & Associates is a U.S.-based multinational company founded in 1958 by Wilbert L. Gore and Genevieve Gore. The company specializes in advanced materials and medical technologies, including implantable medical devices, vascular grafts, surgical meshes, and high-performance fabrics such as Gore-Tex. W. L. Gore & Associates operates globally with manufacturing and research facilities across North America, Europe, and Asia, serving industries such as healthcare, electronics, aerospace, and industrial manufacturing.
- Endologix
Headquarter: Irvine, California, United States.
Endologix is a U.S.-based medical technology company founded in 1992 that specializes in the development and manufacturing of innovative endovascular devices used to treat aortic disorders. The company focuses on minimally invasive solutions for abdominal aortic aneurysm (AAA) repair, including advanced stent graft systems and endovascular technologies. Endologix operates globally with research, development, and manufacturing facilities in the United States and serves healthcare providers across multiple international markets.
- MicroPort Endovascular
Headquarter: Shanghai, China
MicroPort Endovascular is a Chinese medical technology company specializing in the development and manufacturing of endovascular devices used in the treatment of aortic and peripheral vascular diseases. The company operates as a subsidiary of MicroPort Scientific Corporation, which was founded in 1998. MicroPort Endovascular focuses on producing stent graft systems, thoracic and abdominal aortic repair devices, and minimally invasive vascular treatment technologies.
Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the Aortic Endografts Market.
Company Profiles
- Medtronic
- Business Overview
- Company Snapshot
- Products Overview
- Company Market Share Analysis
- Company Coverage Portfolio
- Financial Analysis
- Recent Developments
- Merger and Acquisitions
- SWOT Analysis
- Terumo Aortic
- L. Gore & Associates
- Endologix
- MicroPort Endovascular
- Cook Medical
- Bolton Medica
- CryoLife
- Lombard Medical
- JOTEC
- Abbott Vascular
- Braun Melsungen
- Philips Healthcare
- Siemens Healthineers
- Cardinal Health
- Boston Scientific
- Medicover
- GE Healthcare
- InspireMD
- Cordis Corporation
Our Reports
https://www.sphericalinsights.com/reports/civilized-underground-bunker-market
https://www.sphericalinsights.com/reports/connected-worker-copilot-market
https://www.sphericalinsights.com/reports/ai-powered-content-creation-market
https://www.sphericalinsights.com/reports/industrial-waste-management-market
Conclusion
The global aortic endografts market is poised for steady growth, driven by the increasing prevalence of aortic aneurysms, a rapidly aging population, and the growing adoption of minimally invasive procedures such as EVAR and TEVAR. Advancements in medical technology, including fenestrated and branched endografts, improved delivery systems, and AI-assisted imaging, are enhancing procedural accuracy and patient outcomes. Expanding healthcare infrastructure and rising awareness of early diagnosis, particularly in emerging economies, are further supporting market expansion. Asia Pacific is expected to generate the highest demand due to increasing cardiovascular disease cases and healthcare investments, while North America is projected to grow the fastest with strong innovation and specialized treatment centers.
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Follow Us: LinkedIn | Facebook | Twitter
Need help to buy this report?